What this study is
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
What's being tested
- PET/MR imaging
Intervention · DIAGNOSTIC TEST
undergo PET/MR imaging
- MR imaging
Intervention · DIAGNOSTIC TEST
Undergo MR imaging
- PET/CT imaging
Intervention · DIAGNOSTIC TEST
Undergo PET/CT imaging
Study details
- Sponsor
- Stanford University
- Conditions
- Soft Tissue · Lymphoma · Osteosarcoma
- Enrolling
- 100 people
- Starts
- 2018-02-01
- Est. completion
- 2026-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age Up to 40 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
- We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
- Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.
You can't join if
- Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl.
- Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
- Patient has a CNS primary tumor.
- Pregnant women and fetuses
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openStanford University, School of Medicine
Palo Alto, California, United States
- Anne Muehe · Contact650-720-8601amuehe@stanford.edu
- Heike Daldrup-Link, MD · Principal investigator
Recruiting
Study team
Sponsor
Stanford University
Study ID IRB-44706
Principal investigator
Heike Daldrup-Link, MD
Stanford University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.